“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
JEAN-CLAUDE TARDIF, Montreal Heart Institute
REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans
Improvements in atheroma plaque have been achieved by infusing patients who have acute coronary syndromes with reconstituted high density lipoprotein, HDL, according to investigators from the
…Improvements in atheroma plaque have been achieved by infusing patients who have acute coronary syndromes with reconstituted high density lipoprotein, HDL, according to investigators from the